The drug was initially created by Insilco Medicine to treat idiopathic pulmonary fibrosis. The chronic disease causes the tissue in the lungs to become stiff and thick leading to permanent scarring.
The drug was initially created by Insilco Medicine to treat idiopathic pulmonary fibrosis. The chronic disease causes the tissue in the lungs to become stiff and thick leading to permanent scarring.